Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension

Journal of the American Society of Hypertension

Volumn 9, Issue 11, 2015, Pages 845-854

  Giles, Thomas D ^a   Bakris, George ^b   Oparil, Suzanne ^c   Weber, Michael A ^d   Li, Huiling ^e   Mallick, Madhuja ^e   Bharucha, David B ^e   Chen, Chunlin ^e   Ferguson, William G ^e   Sorin, John ^f   Davis, Matthew ^f   Izzo, Joesph ^f   Andrawis, Nabile ^f   Anderson, Alyn ^f   Bardinas Rodriguez, Rogelio ^f   Young, Douglas ^f   Schreiber, Andrew ^f   Breton, Cristian ^f   Harris, Duane ^f   Lastella, Phillip ^f   Castello, Ramon ^f   Hole, Susan ^f   Lillo, Joesph ^f   Quintero, Luis Carlos ^f   Montenegro, Carlos ^f   Rosen, Jeffrey ^f   Marquez, Farid ^f   Adler, Fredric ^f   Alpizar, Sady ^f   Andersen, James ^f   Anderson, Corey ^f   Calatayud, Graciela ^f   Cannon, Kevin ^f   Cheung, Deanna ^f   Chiong, Rafel ^f   Cohen, Lisa ^f   Collins, Harry ^f   Dao, Michael ^f   Dawson, Cara H ^f   Desantis, Donna ^f   Dunmyer, Shelly ^f   El Harazi, Sherif ^f   Farrington, Cecil M ^f   Ferrera, David ^f   Funk, Gregory S ^f   Gottschlich, Gregory ^f   Hart, Terence T ^f   Kalafer, Marvin ^f   Kereiakes, Dean ^f   Lefebvre, Gigi ^f   Laliotis, Aristolis ^f   Mattar, Peter ^f   McCartney, Michael ^f   McConnehey, Diane ^f   Mello, Curtis ^f   Neutel, Joel ^f   Burke, Deborah A ^f   Pritchard, James ^f   Raad, George ^f   Rankin, Bruce ^f   Reed, John H ^f   Schramm, Erich ^f   Schwartz, Howard ^f   Segall, Nathan ^f   Shoemaker, James ^f   Sial, Vakas ^f   Sligh, Teresa ^f   Smith, William ^f   Stewart, Richard ^f   Streja, Dan ^f   Sugimoto, Danny ^f   White, Alexander ^f   Williams, Hayes ^f   Abraham, William ^f   Ahmed, Azazuddin ^f   Beasley, Richard ^f   Gruener, Daniel ^f   Hsu, Connie ^f   Klein, Ryan ^f   Soo, Allen ^f   Andrews, Charles P ^f   Corder, Clinton ^f   Hurley, Donald ^f   Bretton, Elizabeth ^f   Martinez, Richard ^f   Morin, David ^f   Trevino, Miguel ^f   Arora, Samir ^f   Horn, Curtis Scott ^f   Lovell, Charles ^f   Nussdorfer, Thomas ^f   Weiss, Robert ^f   Bays, Harold ^f   Rhudy, Jackson ^f   Almaguer, Edwardo ^f   Woolley, Joseph H ^f   Miller, Vicki ^f   Moya Hechevarria, Jaynier ^f   Punzi, Henry ^f   Taylor, Addison ^f   Wilson, Jonathan ^f   Alper, Arnold ^f   Buchanan, Patricia ^f   Dobrusin, Richard ^f   Forker, Alan ^f   Krumian, Razmig ^f   Oberstein, Samuel F ^f   Lewin, Andrew ^f   Natividad, Mary Bella ^f   Segui, Armando ^f   Harper, Wayne ^f   Lawless, Andrea ^f   Levinson, Lawrence S ^f   Shah, Shaukat ^f   Blair Britt, Loray ^f   Carmichael, Patrick ^f   Winer, Nathaniel ^f   Grant, David ^f   Rickner, Kyle ^f   Tilley, Absalom ^f   Harper, Linda ^f   Maddock, Stephen ^f   Boscia, Joseph A ^f   Khronusova, Yekaterina ^f   Reed, Larry D ^f   Abboy, Chandar ^f   more..

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c University of Alabama at Birmingham   (United States)

^d Downstate Health Sciences University   (United States)

^e FOREST RESEARCH INSTITUTE   (United States)

^f NONE

Author keywords

ABPM; angiotensin II receptor blocker; biomarkers; Vasodilatory beta blocker

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; NEBIVOLOL; NEBIVOLOL PLUS VALSARTAN; PLACEBO; UNCLASSIFIED DRUG; VALSARTAN; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE; BLOOD; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; FOLLOW UP; MAXIMUM TOLERATED DOSE; PATIENT SELECTION; PROCEDURES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ALDOSTERONE; BLOOD PRESSURE MONITORING, AMBULATORY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MAXIMUM TOLERATED DOSE; NEBIVOLOL; PATIENT SELECTION; RENIN; RENIN-ANGIOTENSIN SYSTEM; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VALSARTAN;

EID: 84947019690     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2015.08.003     Document Type: Article

References (20)

1. S. Atlas The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition J Manag Care Pharm 13 8s-B 2007 s9 s20
2. E.D. Freis, B.J. Materson, and V. Flamenbaum Comparison of propranolol or hydrochlorothiazide alone for treatment of hypertension. III. Evaluation of the renin-angiotensin system Am J Med 74 6 1983 1029 1041
3. R.A. Preston, B.J. Materson, D.J. Reda, D.W. Williams, R.J. Hamburger, W.C. Cushman, and et al. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents JAMA 280 13 1998 1168 1172
4. Y. Gao, and P.M. Vanhoutte Nebivolol: an endothelium-friendly selective beta1-adrenoceptor blocker J Cardiovasc Pharmacol 59 1 2012 16 21
5. H.R. Black, J. Bailey, D. Zappe, and R. Samuel Valsartan: more than a decade of experience Drugs 69 17 2009 2393 2414
6. T.D. Giles, M.A. Weber, J. Basile, A.H. Gradman, D.B. Bharucha, W. Chen, and et al. Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study Lancet 383 9932 2014 1889 1898
7. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., and et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 6 2003 1206 1252
8. C. Seifarth, S. Trenkel, H. Schobel, E.G. Hahn, and J. Hensen Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism Clin Endocrinol (Oxf) 57 4 2002 457 465
9. C.M. Ferrario Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control Life Sci 86 9-10 2010 289 299
10. T.Y. Chan, K.S. Woo, and M.G. Nicholls The application of nebivolol in essential hypertension: a double-blind, randomized, placebo-controlled study Int J Cardiol 35 3 1992 387 395
11. J. Blumenfeld, J. Sealey, S. Mann, A. Bragat, R. Marion, M. Pecker, and et al. Adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects Am J Hypertens 12 1999 451 459
12. C. Czendlik, A. Sioufi, G. Preiswerk, and H. Howald Pharmacokinetic and pharmacodynamic interaction of single doses of valsartan and atenolol Eur J Clin Pharmacol 52 1997 451 459
13. G.S. Stokes, R.M. Graham, and M.A. Weber The role of renin in the antihypertensive action of beta-adrenoreceptor blocking agents Drugs 11 SUPPL 1 1976 150 156
14. B.J. Epstein Aliskiren and valsartan combination therapy for the management of hypertension Vasc Health Risk Manag 6 2010 711 722
15. J.E. Sealey, and J.H. Laragh Aliskiren, the first renin inhibitor for treating hypertension: reactive renin secretion may limit its effectiveness Am J Hypertens 20 5 2007 587 597
16. J.E. Sealey, and J.H. Laragh Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises Am J Hypertens 22 1 2009 112 121
17. M.H. Alderman, S. Madhavan, W.L. Ooi, H. Cohen, J.E. Sealey, and J.H. Laragh Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension N Engl J Med 324 16 1991 1098 1104
18. M.C. Gonzalez, H.W. Cohen, J.E. Sealey, J.H. Laragh, and M.H. Alderman Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients Am J Hypertens 24 11 2011 1181 1186
19. A.S. Bomback, and P.J. Klemmer The incidence and implications of aldosterone breakthrough Nat Clin Pract Nephrol 3 9 2007 486 492
20. B.M. Egan, and J. Li Role of aldosterone blockade in resistant hypertension Semin Nephrol 34 3 2014 273 284